LivaNova PLC (LIVN)Healthcare | Medical Devices | Gloucester, United Kingdom | NasdaqGS
79.12 USD
-3.86
(-4.652%) ⇩
(July 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 5:52 a.m. EDT
LivaNova presents a classic value trap scenario where recent price strength masks a four-year structural decline. Although revenue growth is positive at 14.3%, the stock has lost 15% in the trailing year and sits at the bottom of a nine-year downtrend, capping long-term conviction. The recent surge to near 52-week highs is supported by strong momentum relative to moving averages, but options flow reveals significant defensive positioning with put volume exceeding open interest at key support levels. Without a dividend to cushion the downside, investors are betting on a fundamental turnaround that the market has yet to reward, keeping the long-term outlook cautious despite the short-term technical bounce. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.074488 |
| AutoARIMA | 0.083460 |
| AutoETS | 0.083466 |
| MSTL | 0.096290 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 21.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.150 |
| Excess Kurtosis | -1.42 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 28.353 |
| Revenue per Share | 26.247 |
| Market Cap | 4,346,341,376 |
| Trailing P/E | 40.37 |
| Forward P/E | 17.13 |
| Beta | 0.86 |
| Profit Margins | 7.47% |
| Website | https://www.livanova.com |
As of July 11, 2026, 5:52 a.m. EDT: Implied volatility is significantly elevated on puts compared to calls, with open interest concentrated near the money at strikes 77.5, 80.0, and 82.5. Unusual flow shows put volume exceeding open interest at key support levels, indicating speculators are prioritizing downside protection over upside speculation despite the stock trading near its 52-week high.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.840428 |
| Address1 | 5,220 Valiant Court |
| Address2 | Gloucester Business Park |
| All Time High | 131.54 |
| All Time Low | 32.48 |
| Ask | 101.61 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.8 - Buy |
| Average Daily Volume10 Day | 572,930 |
| Average Daily Volume3 Month | 791,362 |
| Average Volume | 791,362 |
| Average Volume10Days | 572,930 |
| Beta | 0.862 |
| Bid | 58.75 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 22.064 |
| City | Gloucester |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 79.12 |
| Current Ratio | 1.33 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 83.02 |
| Day Low | 78.46 |
| Debt To Equity | 28.353 |
| Display Name | LivaNova |
| Earnings Call Timestamp End | 1,785,960,000 |
| Earnings Call Timestamp Start | 1,785,960,000 |
| Earnings Timestamp | 1,785,933,000 |
| Earnings Timestamp End | 1,785,933,000 |
| Earnings Timestamp Start | 1,785,933,000 |
| Ebitda | 262,486,000 |
| Ebitda Margins | 0.18311001 |
| Enterprise To Ebitda | 15.811 |
| Enterprise To Revenue | 2.895 |
| Enterprise Value | 4,150,078,464 |
| Eps Current Year | 4.252 |
| Eps Forward | 4.618 |
| Eps Trailing Twelve Months | 1.96 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 44 1452 638 530 |
| Fifty Day Average | 75.7213 |
| Fifty Day Average Change | 3.3987045 |
| Fifty Day Average Change Percent | 0.044884395 |
| Fifty Two Week Change Percent | 84.0428 |
| Fifty Two Week High | 85.27 |
| Fifty Two Week High Change | -6.149994 |
| Fifty Two Week High Change Percent | -0.07212377 |
| Fifty Two Week Low | 41.015 |
| Fifty Two Week Low Change | 38.105003 |
| Fifty Two Week Low Change Percent | 0.92905045 |
| Fifty Two Week Range | 41.015 - 85.27 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,445,261,400,000 |
| Float Shares | 54,653,377 |
| Forward Eps | 4.618 |
| Forward P E | 17.13296 |
| Free Cashflow | 198,052,752 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 3,300 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.67855 |
| Gross Profits | 972,665,024 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00418 |
| Held Percent Institutions | 1.12893 |
| Implied Shares Outstanding | 54,933,538 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom. |
| Long Name | LivaNova PLC |
| Market | us_market |
| Market Cap | 4,346,341,376 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_27283 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 107,145,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,558,384,983 |
| Number Of Analyst Opinions | 11 |
| Open | 83.02 |
| Operating Cashflow | 245,590,000 |
| Operating Margins | 0.14393 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.93 |
| Phone | 44 1452 638 500 |
| Pre Market Change | 0.37999725 |
| Pre Market Change Percent | 0.48027962 |
| Pre Market Price | 79.5 |
| Pre Market Time | 1,784,120,511 |
| Previous Close | 82.98 |
| Price Eps Current Year | 18.607716 |
| Price Hint | 2 |
| Price To Book | 3.585932 |
| Price To Sales Trailing12 Months | 3.0320716 |
| Profit Margins | 0.07475 |
| Quick Ratio | 1.009 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.81818 |
| Region | US |
| Regular Market Change | -3.86 |
| Regular Market Change Percent | -4.65172 |
| Regular Market Day High | 83.02 |
| Regular Market Day Low | 78.46 |
| Regular Market Day Range | 78.46 - 83.02 |
| Regular Market Open | 83.02 |
| Regular Market Previous Close | 82.98 |
| Regular Market Price | 79.12 |
| Regular Market Time | 1,784,059,201 |
| Regular Market Volume | 828,625 |
| Return On Assets | 0.05271 |
| Return On Equity | 0.09543 |
| Revenue Growth | 0.143 |
| Revenue Per Share | 26.247 |
| Sand P52 Week Change | 0.2043345 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 54,933,538 |
| Shares Percent Shares Out | 0.0717 |
| Shares Short | 3,939,424 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 3,340,286 |
| Short Name | LivaNova PLC |
| Short Percent Of Float | 0.082399994 |
| Short Ratio | 4.64 |
| Source Interval | 15 |
| Symbol | LIVN |
| Target High Price | 95.0 |
| Target Low Price | 67.0 |
| Target Mean Price | 81.45455 |
| Target Median Price | 81.0 |
| Total Cash | 539,705,984 |
| Total Cash Per Share | 9.825 |
| Total Debt | 343,443,008 |
| Total Revenue | 1,433,456,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.96 |
| Trailing P E | 40.367348 |
| Trailing Peg Ratio | 0.9256 |
| Triggerable | 1 |
| Two Hundred Day Average | 64.64595 |
| Two Hundred Day Average Change | 14.474052 |
| Two Hundred Day Average Change Percent | 0.22389728 |
| Type Disp | Equity |
| Volume | 828,625 |
| Website | https://www.livanova.com |
| Zip | GL3 4FE |